Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1998-11-16
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0192-6233
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
582-3
|
pubmed:dateRevised |
2009-7-1
|
pubmed:meshHeading |
pubmed-meshheading:9715519-Animals,
pubmed-meshheading:9715519-Carcinogenicity Tests,
pubmed-meshheading:9715519-Carcinogens,
pubmed-meshheading:9715519-Humans,
pubmed-meshheading:9715519-Mice,
pubmed-meshheading:9715519-Mice, Transgenic,
pubmed-meshheading:9715519-Neoplasms,
pubmed-meshheading:9715519-Risk Assessment
|
pubmed:articleTitle |
Cancer hazard identification: toward simplification and interpretability.
|
pubmed:affiliation |
Boehringer-Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877-0368, USA.
|
pubmed:publicationType |
Journal Article
|